FSMAX
Price
$117.36
Change
+$1.57 (+1.36%)
Updated
Jul 9 closing price
Net Assets
43.48B
VYMYX
Price
$19.04
Change
+$0.29 (+1.55%)
Updated
Jul 9 closing price
Net Assets
143.46M
Interact to see
Advertisement

FSMAX vs VYMYX

FSMAX vs VYMYX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. VYMYX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a StrongBuy and VYMYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 43.5B vs. VYMYX (143M). VYMYX pays higher dividends than FSMAX: VYMYX (0.52) vs FSMAX (0.48). FSMAX was incepted earlier than VYMYX: FSMAX (15 years) vs VYMYX (15 years). VYMYX (0.82) is less costly to investors than FSMAX (0.04). VYMYX is a more actively managed with annual turnover of: 72.00 vs. FSMAX (23.00). FSMAX has a lower initial minimum investment than VYMYX: FSMAX (0) vs VYMYX (1000). FSMAX annual gain was more profitable for investors over the last year : 22.37 vs. VYMYX (-5.42). FSMAX return over 5 years is better than : 33.93 vs. VYMYX (-10.55).
FSMAXVYMYXFSMAX / VYMYX
Total Expense Ratio0.040.705%
Annual Report Gross Expense Ratio0.040.824%
Fund Existence15 years15 years-
Gain YTD15.01915.74195%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets43.5B143M30,420%
Annual Yield % from dividends0.480.5293%
Returns for 1 year22.37-5.42-413%
Returns for 3 years65.838.29794%
Returns for 5 years33.93-10.55-322%
Returns for 10 years139.9828.42492%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGLUX60.400.95
+1.60%
Baron Global Opportunity R6
MISIX21.61N/A
N/A
Victory Trivalent International Sm-Cp I
BIPSX51.89N/A
N/A
ProFunds Biotechnology UltraSector Svc
CMCRX51.22N/A
N/A
Calvert US Mid Cap Core Rspnb Idx R6
RERCX60.29N/A
N/A
American Funds EUPAC R-3